esflurbiprofen
Small moleculeexperimental
Clinical trial activity
10 trials · 10 clinical orgs · 0 marketing orgs
Phase 1
5
Phase 2
5
Phase 3
3
Phase 4
0
Earliest trial started Jun 1, 2016 (NCT02729207)
Timeline
Indications
Mechanism of action
- CyclooxygenaseINHIBITOR
Cyclooxygenase inhibitor
Chemistry & pharmacology
Loading structure…
SMILES
C[C@H](C(=O)O)c1ccc(-c2ccccc2)c(F)c1- Mol. weight
- 244.26 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Delivery
- Topical
Oral
No
Parenteral
No
Topical
Yes
Sources
- ChEMBLCHEMBL435298 ↗
Also known as
- esflurbiprofen
- esflurbiprofen
- esflurbiprofen
- esflurbiprofen
- esflurbiprofen
- esflurbiprofen
- s-flurbiprofen
- s-flurbiprofen
- tt-063
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07307794 | Phase 1 | Jan 31, 2026 | ClinSearch, LLC, CRM Biometrics GmbH, HWI pharma services GmbH, SocraMetrics GmbH, SocraTec R&D GmbH, Teikoku Seiyaku Co., Ltd. |
| NCT06866613 | Phase 3 | Mar 31, 2025 | ClinSearch, LLC, CRM Biometrics GmbH, HWI pharma services GmbH, SocraMetrics GmbH, SocraTec R&D GmbH, Teikoku Seiyaku Co., Ltd. |
| NCT06870422 | Phase 1 | Feb 28, 2025 | HWI pharma services GmbH, SocraMetrics GmbH, SocraTec R&D GmbH, Teikoku Seiyaku Co., Ltd. |
| NCT06871046 | Phase 3 | Feb 20, 2025 | ClinSearch, LLC, CRM Biometrics GmbH, HWI pharma services GmbH, SocraMetrics GmbH, SocraTec R&D GmbH, Teikoku Seiyaku Co., Ltd. |
| NCT06823284 | Phase 1 | Jan 21, 2025 | HWI pharma services GmbH, SocraMetrics GmbH, SocraTec R&D GmbH, Teikoku Seiyaku Co., Ltd. |
| NCT06042192 | Phase 1 | Sep 18, 2023 | ClinSearch, LLC, CRM Biometrics GmbH, SocraMetrics GmbH, SocraTec R&D GmbH, Teikoku Seiyaku Co., Ltd. |
| NCT04908748 | Phase 2 | May 20, 2021 | Clinigen, ClinSearch, LLC, CRM Biometrics GmbH, Teikoku Seiyaku Co., Ltd. |
| NCT04505787 | Phase 1 | Jul 24, 2020 | SocraMetrics GmbH, SocraTec R&D GmbH, Teikoku Seiyaku Co., Ltd. |
| NCT03434197 | Phase 3 | Feb 5, 2018 | Siloam Hospitals, Taisho Pharmaceutical |
| NCT02729207 | Phase 2 | Jun 1, 2016 | Shin Nippon Biomedical Laboratories, Teikoku Seiyaku Co., Ltd. |
Showing 10 of 10 trials
Page 1 / 1
Organizations
Research & Development (10)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Teikoku Seiyaku Co., Ltd. | For profit | 9 | 8 | 3 | 2016 |
| SocraMetrics GmbH | For profit | 7 | 0 | 2 | 2020 |
| SocraTec R&D GmbH | For profit | 7 | 1 | 2 | 2020 |
| ClinSearch, LLC | For profit | 5 | 0 | 3 | 2021 |
| CRM Biometrics GmbH | For profit | 5 | 0 | 3 | 2021 |
| HWI pharma services GmbH | For profit | 5 | 0 | 2 | 2025 |
| Clinigen | For profit | 1 | 0 | 1 | 2021 |
| Shin Nippon Biomedical Laboratories | For profit | 1 | 0 | 1 | 2016 |
| Siloam Hospitals | Academic/Hospital | 1 | 0 | 1 | 2018 |
| Taisho Pharmaceutical | For profit | 1 | 1 | 1 | 2018 |
10 organizations
Page 1 / 1